Home Stock

Stock Research: Baxter

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Baxter

NYQ:BAX US0718131099
87
  • Value
    100
  • Growth
    13
  • Safety
    Safety
    73
  • Combined
    80
  • Sentiment
    79
  • 360° View
    360° View
    87
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Baxter International Inc. is a global medtech company providing a portfolio of diagnostic, critical care, nutrition, hospital, and surgical products. It operates in the medical products and therapies, healthcare systems and technologies, and pharmaceuticals industries. In the last fiscal year, the company had a market cap of $14,497 million, profits of $4,046 million, revenue of $10,636 million, and 38000 employees.

more

ANALYSIS: With an Obermatt 360° View of 87 (better than 87% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Baxter are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Baxter. The consolidated Value Rank has an attractive rank of 100, which means that the share price of Baxter is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 100% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 73. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 79. But the consolidated Growth Rank has a low rank of 13, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 87 of its competitors have better growth. ...read more

more
Strongest Rank Analyst Opinions
Weakest Rank Value
Country USA
Industry Health Care Equipment
Size X-Large
Website baxter.com
Index
D.J. US Health Care
D.J. US Medical Equipment
S&P 500
Baxter stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
100 94 98 89
Growth
13 25 9 91
Safety
Safety
73 27 44 98
Sentiment
79 50 40 38
360° View
360° View
87 38 36 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
9 3 5 45
Opinions Change
50 50 31 23
Pro Holdings
n/a 66 67 30
Market Pulse
79 83 82 90
Sentiment
79 50 40 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
100 94 98 89
Growth
13 25 9 91
Safety Safety
73 27 44 98
Combined
80 30 51 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
87 57 74 48
Price vs. Earnings (P/E)
50 55 64 50
Price vs. Book (P/B)
65 52 41 44
Dividend Yield
89 90 96 94
Value
100 94 98 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
19 55 27 69
Profit Growth
82 39 19 60
Capital Growth
19 24 51 62
Stock Returns
15 37 39 79
Growth
13 25 9 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
26 18 13 46
Refinancing
85 43 69 97
Liquidity
67 61 60 84
Safety Safety
73 27 44 98

Similar Stocks

Discover high‑ranked alternatives to Baxter and broaden your portfolio horizons.

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Resideo Technologies

NYQ:REZI
Country: USA
Industry: Building Products
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews